These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 39157460)

  • 1. Update on non-infectious uveitis treatment: anti-TNF-alpha and beyond.
    Chauhan K; Tyagi M
    Front Ophthalmol (Lausanne); 2024; 4():1412930. PubMed ID: 39157460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Pharmacological Strategies for the Treatment of Non-Infectious Uveitis. A Minireview.
    Valenzuela RA; Flores I; Urrutia B; Fuentes F; Sabat PE; Llanos C; Cuitino L; Urzua CA
    Front Pharmacol; 2020; 11():655. PubMed ID: 32508634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis and current therapies for non-infectious uveitis.
    Wu X; Tao M; Zhu L; Zhang T; Zhang M
    Clin Exp Med; 2023 Aug; 23(4):1089-1106. PubMed ID: 36422739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biotherapies in Uveitis.
    Leclercq M; Desbois AC; Domont F; Maalouf G; Touhami S; Cacoub P; Bodaghi B; Saadoun D
    J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33171664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of immunomodulators in non-infectious uveitis: lights and shadows.
    Bernal-Morales C; Ramanan AV; Pavesio C
    Eye (Lond); 2024 Dec; 38(17):3231-3242. PubMed ID: 39160332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspectives for immunotherapy in noninfectious immune mediated uveitis.
    Touhami S; Gueudry J; Leclercq M; Touitou V; Ghembaza A; Errera MH; Saadoun D; Bodaghi B
    Expert Rev Clin Immunol; 2021 Sep; 17(9):977-989. PubMed ID: 34264142
    [No Abstract]   [Full Text] [Related]  

  • 7. Update on the systemic management of noninfectious uveitis in children and adolescents.
    Leal I; Steeples LR; Wong SW; Giuffrè C; Pockar S; Sharma V; Green EKY; Payne J; Jones NP; Chieng ASE; Ashworth J
    Surv Ophthalmol; 2024; 69(1):103-121. PubMed ID: 36682467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New therapies in development for the management of non-infectious uveitis: A review.
    Hassan M; Karkhur S; Bae JH; Halim MS; Ormaechea MS; Onghanseng N; Nguyen NV; Afridi R; Sepah YJ; Do DV; Nguyen QD
    Clin Exp Ophthalmol; 2019 Apr; 47(3):396-417. PubMed ID: 30938012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab in the Treatment of Non-Infectious Uveitis: A Review.
    Cao H; Ma X
    J Inflamm Res; 2024; 17():6765-6780. PubMed ID: 39364118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges for further successful development of tumor necrosis factor targeting therapies for uveitis.
    Thng ZX; Regenold J; Bromeo AJ; Akhavanrezayat A; Than NTT; Khatri A; Mohammadi SS; Tran ANT; Shin YU; Karaca I; Ghoraba HH; Or CCM; Nguyen QD
    Expert Opin Investig Drugs; 2024 Feb; 33(2):95-104. PubMed ID: 38299551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological and Therapeutic Role of Interleukin-6 in Non-Infectious Uveitis: A Narrative Review.
    Cifuentes-González C; Mejía-Salgado G; Rojas-Carabali W; Diez-Bahamón LA; Garzón-Dangond JM; Janela B; de-la-Torre A; Agrawal R
    Ocul Immunol Inflamm; 2024 Oct; ():1-15. PubMed ID: 39404707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologics for the treatment of noninfectious uveitis: current concepts and emerging therapeutics.
    Thomas AS
    Curr Opin Ophthalmol; 2019 May; 30(3):138-150. PubMed ID: 30844945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of intravitreal anti-tumour necrosis factor drugs in adults with non-infectious uveitis - a systematic review.
    Leal I; Rodrigues FB; Sousa DC; Romão VC; Duarte GS; Carreño E; Dick AD; Marques-Neves C; Costa J; Fonseca JE
    Acta Ophthalmol; 2018 Sep; 96(6):e665-e675. PubMed ID: 29577629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adalimumab in the treatment of non-infectious uveitis.
    Burek-Michalska A; Turno-Kręcicka A
    Adv Clin Exp Med; 2020 Oct; 29(10):1231-1236. PubMed ID: 33125196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New observations and emerging ideas in diagnosis and management of non-infectious uveitis: A review.
    Rosenbaum JT; Bodaghi B; Couto C; Zierhut M; Acharya N; Pavesio C; Tay-Kearney ML; Neri P; Douglas K; Pathai S; Song AP; Kron M; Foster CS
    Semin Arthritis Rheum; 2019 Dec; 49(3):438-445. PubMed ID: 31301816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Knowledge of Biologics in Treatment of Noninfectious Uveitis.
    Gupta S; Shyamsundar K; Agrawal M; Vichare N; Biswas J
    J Ocul Pharmacol Ther; 2022 Apr; 38(3):203-222. PubMed ID: 35133890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local versus Systemic Therapy for Noninfectious Uveitis (NIU).
    Chang EL; Sobrin L
    Semin Ophthalmol; 2023 Jan; 38(1):15-23. PubMed ID: 36471661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging drugs for uveitis.
    Larson T; Nussenblatt RB; Sen HN
    Expert Opin Emerg Drugs; 2011 Jun; 16(2):309-22. PubMed ID: 21210752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of Janus Kinase Inhibitors as Therapies for Noninfectious Uveitis.
    Juan HY; Sheu SJ; Hwang DK
    J Ocul Pharmacol Ther; 2024 Sep; ():. PubMed ID: 39315932
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.